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S U M M A R Y
Objectives: The widespread epidemic of Zika virus infection in South and Central America and the
Caribbean in 2015, along with the increased incidence of microcephaly in fetuses born to mothers
infected with Zika virus and the potential for worldwide spread, indicate the need to review the current
literature regarding vectors, reservoirs, and ampliﬁcation hosts.
Vectors: The virus has been isolated in Africa in mosquitoes of the genera Aedes, Anopheles, and Mansonia,
and in Southeast Asia and the Paciﬁc area in mosquitoes of the genus Aedes. Aedes albopictus has invaded
several countries in Central Africa and all Mediterranean countries, and continues to spread throughout
Central and Northern Europe. The wide distribution of the virus in animal hosts and vectors favors the
emergence of recombinants.
Animal hosts: The virus has been isolated in monkeys, and antibodies have been detected in domestic
sheep, goats, horses, cows, ducks, rodents, bats, orangutans, and carabaos.
Conclusions: It is a public health imperative to deﬁne the domestic and wild animal reservoirs,
ampliﬁcation hosts, and vector capacity of the genera Aedes, Anopheles, and Mansonia. These variables
will deﬁne the geographic distribution of Zika virus along with the indicated timing and scale of the
environmental public health interventions worldwide.
 2016 The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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A widespread epidemic of Zika virus (ZIKV) infection was
reported in 2015 in Central and South America and the Caribbean.
This epidemic was associated with an increased incidence of
microcephaly in fetuses born to mothers infected with ZIKV, with
Brazil being the country most affected by both epidemics.1–4 This
rare, devastating, and untreatable complication of the fetus was
declared a public health emergency of international concern
(PHEIC).1–4 The neurotropism of the virus was recognized early,5
and this has been evident in the recent rise in microcephaly
incidence in Brazil .3,4,6 The virus has been found in the amniotic
ﬂuid of two pregnant women with fetuses suffering a reduction in
the circumference of the head.6 The virus has also been found in the
central nervous system (CNS) of fetuses,3,4 with negative tests
excluding other congenital infections.6E-mail address: vorou@keelpno.gr.
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1201-9712/ 2016 The Author. Published by Elsevier Ltd on behalf of International Soc
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Thirty-two countries and territories of the Americas are
affected by ZIKV, in addition to Rio de Janeiro, Brazil, where the
Olympics and Paralympics are due to be held in August 2016; this
poses a threat to international travelers and the local host-country
residents .2 Local transmission has not been observed in Europe
yet, and there is a global alert for travelers returning from endemic
countries with symptoms consistent with ZIKV infection.
The immediate public health measures feasible at present, in
the absence of a vaccine, are interventions relevant to the vector
and a better understanding of the wide and unknown range of
possible ampliﬁcation hosts. Two main concerns prompted this
exhaustive review of the literature: the historical paradigm of the
introduction of yellow fever virus from Africa to the Americas,
where it adapted to local sylvatic vectors and primates,7 and the
fact that we do not yet know which could be the competent vectors
or amplifying hosts of ZIKV in temperate climate regions, thus
hampering any future surveillance and intervention control
programs. The range of vectors and animals in which the virus
has been detected worldwide was reviewed in order to assess the
likelihood of an established circulation of the virus in novel areas.iety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Lineages of Zika virus
1. African lineages (two clusters) 2. Asian lineage
a. MR 766 cluster One Asian genotype
b. Nigerian cluster
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ZIKV is an emerging vector-borne pathogen that was ﬁrst
isolated in 1947 in a sentinel rhesus macaque monkey and again in
1948 from a pooled specimen of Aedes africanus mosquitoes from
the Zika Forest in Uganda.5 During the years 1947 through 2007,
only serological data, entomological data, and the diagnosis of
14 human cases with viral isolation or serology were reported from
Asia and Africa.8–13 It has been speculated that among those
human cases, a few may have represented an unrecognized
outbreak. One unrecognized outbreak took place in 1977–1978 in
Indonesia.14,15 The ﬁrst outbreak outside of Africa and Asia
occurred in 2007, on Yap Island in the Federated States of
Micronesia, with 49 conﬁrmed cases and 73% of residents aged 3
years infected according to IgM seropositivity.16,17 There are
limitations to the seroprevalence studies resulting from the cross-
reactive nature of ZIKV with dengue and other ﬂaviviruses.
However, IgM antibodies against dengue virus persist for up to
12 weeks, and the specimens for the IgM measurement were
collected during a 12-week period from April 1 through July 31,
2007. During this time, the specimens had been collected within
10 days from symptom onset. They tested positive only for ZIKV
RNA and not for dengue or other ﬂavivirus RNA.17
From 2007 through 2013, no new instances of human seroposi-
tivity or disease were reported. In 2013, the virus reemerged in
French Polynesia, and from 2013 through 2014, it disseminated to
the Cook Islands, New Caledonia, Easter Island, and throughout the
Paciﬁc.18 French Polynesia reported 396 epidemiologically con-
ﬁrmed cases and 29 000 suspected cases.19 The virus has been
isolated or has had its nucleic acid extracted by PCR and then
sequenced from samples collected in Southeast Asia (e.g., Thailand,
Indonesia, Cambodia20–22). All strains collected in Asia and the
Paciﬁc belong to the Asian lineage and are closely related, indicating
that the virus was present in the area for several years but remained
undetected, as the clinical manifestations resemble those of other
known endemic arboviruses such as dengue virus and chikungunya
virus.20 However, the possibility that the virus has spread to the
Paciﬁc and Southeast Asia successively, causing a wave of clinical
disease and subsequent detection of the virus, cannot be excluded.20
In March 2015, Brazil notiﬁed the World Health Organization of
an illness compatible with but not suspected to be a ZIKV infection.
Soon after, in May 2015, it documented the ﬁrst conﬁrmed ZIKV
transmission in mainland South America, along with the assump-
tion that the virus had been introduced to the country via the Va’a
World Sprint Championship canoe race held in Rio de Janeiro in
August 2014.23 Four Paciﬁc countries participated (French Poly-
nesia, New Caledonia, the Cook Islands, and Easter Island). The
virus was subsequently transferred from the major cities across the
country via the infected Brazilian participants and spectators who
returned to their home towns.24 The strain found in Brazil was
phylogenetically closer to the strain in the French Polynesia
outbreak of 2013–2014, with both belonging to the Asian lineage.
It is estimated that 440 000 to 1.3 million cases had been reported
as of December 2015.23
3. Virus
ZIKV is an approximately 11-kb single-stranded, positive-sense
ribonucleic acid (RNA) virus of the Flaviviridae family. It is related
to dengue, West Nile, and Yellow fever viruses and is a member of
the Spondweni serocomplex, whose transmission cycle consists
mainly of vectors from the Aedes genus mosquitoes (A. furcifer, A.
taylori, A. luteocephalus, and A. africanus) and monkeys.25,26
Phylogenetic analyses have revealed three lineages: two African
lineages, i.e., the MR 766 cluster and the Nigerian cluster, and one
Asian lineage (Table 1).16,27,28All lineages share a common origin in Uganda early in the 20th
century, from where it dispersed west to West Africa via two
introductions and east to Southeast Asia and then to the Paciﬁc as
follows: (1) a relative of the MR 766 prototype strain was introduced
from Uganda to Coˆte d’Ivoire in 1940 and from there to Senegal in
1985 resulting in the MR 766 lineage; (2) a relative of the Nigerian
strain was introduced from Uganda to the Central African Republic
and Nigeria around 1935, and from Nigeria to Senegal and Coˆte
d’Ivoire around 1960, forming the Nigerian lineage; and (3) a ZIKV
cluster was probably spread from Uganda to Malaysia in 1945,
making its way to Micronesia sometime around 1960, where it
formed the Asian lineage.25 However, it is unknown whether to
attribute this migration only to human and vector movements, or
also to birds carrying the virus along migratory routes.
Regarding the African lineages, the phylogenetic analysis of
ZIKV strains collected from 1968 through 2002 in Senegal, Coˆte
d’Ivoire, Burkina Faso, and the Central African Republic indicated
that there are more recombinants than in other ﬂaviviruses;
however, they all clustered in the two African lineages, the MR
766 cluster and the Nigerian cluster.
4. Transmission
Transmission has been demonstrated to occur mostly via
infected female mosquito vectors of the Aedes genus (Culicidae
family). Transmission is mainly urban and sylvatic, with humans
serving as primary ampliﬁcation hosts in areas where there are no
non-human primates.17 The latter constitute the ampliﬁcation
host in a sylvatic cycle.17 Mosquitoes, as hematophagus arthro-
pods, acquire the virus via a blood meal, and they host it
throughout their life-span without being affected. They transmit it
to the next ampliﬁcation host, i.e., their target during the next
blood meal.29 Other routes of transmission are sexual inter-
course,30–33 perinatal transmission from mother to fetus,34 and
blood transfusion.35 Breast feeding has not been reported as a
mode of transmission.
5. Clinical manifestations
The majority of infections are subclinical, estimated to reach
81% of infected individuals. The clinical manifestations mimic
those of other arboviral infections, e.g., dengue and the chikungu-
nya endemic in tropical areas (West Africa, Southeast Asia, Paciﬁc
area, South America).2,17,22,36 A macular or papular rash (90%),
fever (65%), arthritis or arthralgia (65%), non-purulent conjuncti-
vitis (55%), myalgia (48%), headache (45%), and retro-orbital pain
(39%) have been the most commonly reported symptoms,20
followed by anorexia, vomiting, diarrhea, stomach aches, dizziness,
leg pain, lymphadenopathy, and hypotension. No deaths, hospi-
talizations, or hemorrhagic manifestations have been documen-
ted.17,20 In the Indonesian outbreak among humans in 1977–1978,
no rash was reported.14 In Eastern Nigeria, two patients presented
jaundice.37
There was early evidence of neurotropism of the virus,5 which
spares all body tissue except for nervous tissue.38 Intracerebral
inoculation of infected human blood in suckling albino Swiss mice
was followed by proliferation of the virus in their nervous tissue.8
ZIKV infection has been associated with Guillain–Barre´ syndrome
(GBS) in Martinique and French Polynesia.39,40 During the ZIKV
outbreak in French Polynesia in 2013–2014, the incidence of GBS
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patients conﬁrmed the link between ZIKV infection and GBS.
Further, the same study did not ﬁnd any evidence that past or
concurrent dengue infection was a causative or predisposing factor
for GBS.41 Additionally, microcephaly and various ophthalmologi-
cal ﬁndings and neurological symptoms have been observed in
fetuses and infants born to infected mothers.1–4 The autopsy
ﬁndings in the CNS of fetuses were a very small brain, complete
absence of the cerebral gyri, severe dilation of both cerebral lateral
ventricles, dystrophic calciﬁcations throughout the cerebral
cortex, and hypoplasia of the brain stem and spinal cord. Particles
consistent with ZIKV were detected on electron microscopy of
brain tissue, but not in other tissues.3,4
6. Diagnosis
It is challenging to diagnose pregnant women or symptomatic
individuals living in or returning from areas endemic for
ﬂaviviruses. Flaviviruses trigger the production of cross-reactive
antibodies in humans, and they cause dengue, Japanese encepha-
litis, Saint Louis encephalitis, West Nile fever, yellow fever, and
Zika infection, diseases that share some similar symptoms.42–44
The emphasis for diagnostics should be on molecular testing, such
as reverse-transcription PCR (RT-PCR), during the ﬁrst 7 days after
symptom onset. After the 7th day, viremia decreases gradually;
consequently, a negative RT-PCR does not exclude ﬂavivirus
infection, and serological testing should be performed.20 IgMTable 2
Mosquitoes in which Zika virus has been detected
Year of sampling Location Mosquito genus and species 
Africa
1948 Zika Forest, Uganda Aedes africanus 
1958 Zika Forest, Uganda Aedes africanus 
1964 Zika Forest, Uganda Aedes africanus 
1969 Uganda, Bwamba county,
Zika Forest
Aedes africanus, Aedes apicorgen
1976–1980 Central African Republic Aedes africanus, Aedes opok 
1968–2002 West Africa: Coˆte d’Ivoire,
Senegal, Burkina Faso,
Central Africa Republic
Aedes dalzieli, Aedes africanus, Ae
furcifer, Aedes grahamii, Aedes lut
vittatus, Aedes opock
1962–2008 Senegal Aedes aegypti, Aedes dalzieli, Aed
furcifer (known as Aedes taylori)
luteocephalus, Aedes vittatus, Aed
Aedes metallicus, Aedes minutus,
africanus, Anopheles coustani, co
gambiae s.l., Mansonia uniformis
number of ZIKV isolation events
Aedes furcifer (known as Aedes t
luteocephalus, and Aedes dalzieli
2011 Southeastern Senegal Aedes africanus, Aedes hirsutus, A
Aedes unilineatus, and Culex per
highest infection rates compare
(Diceronyia) furcifer, Aedes (Fredw
Aedes taylori, Aedes luteocephalu
Aedes aegypti, Mansonia uniform
coustani, with the lower infectio
2007 Gabon Aedes albopictus 
Asia
1969 Malaysia Aedes aegypti 
NA; experiment
in 2012
Singapore (Local in Singapore) Aedes aegyp
NA; experiment
in 2014
Yap Island,
Federated States
of Micronesia;
human outbreak in 2007
Field collected Aedes henselli an
quinquefasciatus tested negative
henselli laboratory infection
ZIKV, Zika virus; NA, not applicable.antibodies persist for about 2 to 12 weeks and can be detected by
ELISA. If this assay is positive, neutralizing antibody detection
assays, e.g., plaque reduction neutralization tests (PRNT), may
enable us to identify the virus causing infection.43,44
Conﬁrmation of the diagnosis of ZIKV infection relies on the
detection of ZIKV RNA (RNA extraction) in blood through RT-PCR or
pan-ﬂavivirus PCR ampliﬁcation, followed by sequencing, or virus
isolation. Alternatively, a conﬁrmatory diagnosis may be achieved
with the co-detection of anti-ZIKV IgM antibodies (ELISA) and a
ZIKV PRNT90 (or PRNT80) titer of at least 20, and if West Nile virus
or dengue virus needs to be ruled out, a ratio of ZIKV to either
dengue virus or West Nile virus PRNT titers of 4. In contrast, a
probable case of ZIKV infection tests negative by RT-PCR but
positive for IgM antibody (ELISA), and has a ZIKV PRNT titer of at
least 20, and a ratio of ZIKV to dengue virus or to West Nile virus
PRNT titers of <4.17,20,43,45
The detection of the virus in pooled specimens of mosquitoes is
performed with quantitative real-time PCR.46
7. Vectors
The vectors of ZIKV in Africa are distinct from those in South
America, Southeast Asia, and the Paciﬁc area. Outside Africa, Aedes
aegypti is the principal vector, while Aedes albopictus is also
becoming established as a competent vector (Table 2).
In Africa, ZIKV was ﬁrst isolated from Aedes africanus mosqui-
toes collected in Zika Forest, Bwamba county, Uganda, in 1948,5Study/assay Ref.
Mosquito catches in Zika Forest and ﬁrst isolation
of ZIKV from Aedes africanus pooled specimens
5,38
Virus isolation 47
Virus isolation 10
teus Virus isolation from pooled specimens of
mosquitoes trapped in Zika Forest
12
Retrospective entomological study with RT-PCR
and sequencing
48
des aegypti, Aedes
eocephalus, Aedes
Retrospective study; phylogenetic analysis,
reverse transcription PCR, nucleotide sequencing;
numerous recombination events were detected
25
es fowleri, Aedes
, Aedes
es neoafricanus,
 Anopheles
ustani, Anopheles
 (the higher
 was detected in
aylori), Aedes
)
Virus isolation in the mosquito cell line AP61
(Aedes pseudoscutellaris)
Identiﬁcation of isolates by immunoﬂuorescence
with virus-speciﬁc immune ascitic ﬂuid; this was
conﬁrmed by complement ﬁxation or
neutralization tests
49
edes metallicus,
fuscus had the
d to Aedes
ardsius) vittatus,
s, Aedes dalzieli,
is, and Anopheles
n rates
Virus isolation, RT-PCR 50
Retrospective sero-epidemiological and
entomological study in 2014; RT-PCR and
sequencing of pooled specimens
36
Virus isolation 11
ti Inoculation of Ugandan ZIKV in (local in
Singapore) Aedes aegypti and subsequent
mosquito-borne transmission of the virus
54
d Culex
 for ZIKV; Aedes
Experiment; laboratory infection of Aedes henselli 55
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and Aedes apicoergenteus collected in Zika Forest, Uganda.12 In
2014, a retrospective study investigated A. africanus and Aedes opok
collected in the Central African Republic, West Africa, from
1976 through 1980. The phylogenetic analysis of this research
revealed that the detected ZIKV strains clustered together in the
African lineages of ZIKV.48 Viral isolates from the years 1968 to
2002 in West Africa revealed that ZIKV detected in Aedes dalzieli, A.
africanus, A. aegypti, and A. furcifer exhibited many recombination
events, which could be attributed principally to the zoophilic
mosquito A. dalzieli, which takes blood meals from distinct animal
species harboring different ZIKV strains at the same time.25
Another retrospective study in Senegal, West Africa, investigated
samples collected from 1962 through 2008 and detected the ZIKV
in Aedes aegypti, Aedes dalzieli, Aedes furcifer (known as A. taylori),
Anopheles africanus, Anopheles coustani , Anopheles gambiae s.l., and
Mansonia uniformis.49 In 2011, in southeastern Senegal, ZIKV was
isolated from M. uniformis, Culex perfuscus, and Anopheles coustani,
but without adequate clariﬁcation of their vector competency.50Table 3
Animals in which Zika virus was detected
Year of sampling Location Animal Assay vir
1947 Zika Forest, Uganda Rhesus monkeys Intracereb
into mice
virus isol
1967–1968
1962 and 1964
Senegal 1967–1968
Ethiopia 1962 and 1964
Wild mammals, monkeys Antibody
HI
1969 Uganda, Kisubi, Bwamba
county, Zika Forest
Bwamba county
monkeysa
Antibody
HI test
1978 Lombok, Indonesia;
human outbreak in 1977
Ducks, goats, cows,
horses, bats, rats, carabaos
(water buffalo)
HI antibo
detection
(DA)
1982 Gabon Monkeys Antibody
HI/compl
test
1983 Pakistan Rodents, domestic sheep
and goats (at slaughter),
humans
Antibody
1996–1997 Malaysia, Borneo Wild orangutans, semi-
captive orangutans
Antibodie
1968–2002 West Africa: Coˆte d’Ivoire
and Senegal, Burkina Faso,
Central Africa Republic;
retrospective study of
viral isolates
Monkeys RT-PCR, n
sequencin
recombin
1962–2008 Senegal; retrospective
study of viral isolates
Monkey (Erythrocebus
patas), Chlorocebus
aethiops (also named
grivet and African green
monkey)
Virus isol
mosquito
(Aedes ps
identiﬁca
by immu
with viru
immune 
conﬁrmed
complem
neutraliza
HI, hemagglutination inhibition; NA, not applicable.
a Red-tail monkey, black mangabey, and lowland colobus were positive for Zika viruHowever, in 2007, the ﬁrst human infection with ZIKV was
recognized in Gabon, Central Africa, as a result of the presence of A.
albopictus, a species that has invaded the urban areas of the
country.36 Until then, the ZIKV epidemic had gone unrecognized as
a result of the co-existence with dengue and chikungunya
viruses.36 A. albopictus has invaded Cameroon in Central Africa
and Mozambique in Southeast Africa, gradually replacing the
indigenous A. aegypti,51 and depicts a dynamic expansion in
temperate climates across the globe.52
In the Paciﬁc, vectors of ZIKV are mosquitoes of the genus Aedes,
principally the prevalent A. aegypti, followed by the invading A.
albopictus,53 which are known to transmit chikungunya virus,
dengue virus, and ZIKV.42 They are considered to be competent
vectors of the ZIKV Asian lineage, and their prevalence increased
from 2011 to 2014.42 ZIKV was isolated from A. aegypti in Malaysia
in 1969.11 In Indonesia in 1978, a human epidemic of ZIKV was
presumably propagated by A. aegypti during the rainy season, but
no study has been conducted to establish the presence of the virus
in mosquitoes.14 In Singapore, the experimental inoculation ofus/antibody Number of animals tested Positive animals (%) Ref.
ral inoculation
 and subsequent
ation
One rhesus diagnosed with the virus; two others
underwent successful experimental inoculation
5, 38
 detection with Not reported Wild mammals 2.4%,
monkeys 25%
61
 detection with Kisubi red-tail 21
Bwamba red-tail 52
Bwamba others 16
4/21
23/52
7/16
12
dies (HIA) and
 of antibodies
HIA:
15 horses
41 cows
13 carabaos
35 goats
78 chickens
52 ducks
71 bats
25 rats
17 wild birds
DA:
6 horses, 8 cows,
1 carabao, 9 goats,
1 chicken, 2 ducks, 1 bat
HIA:
3/15 (20%)
4/41 (10%)
1/13 (8%)
7/35 (20%)
0/78 (0)
2/52 (4%)
6/71 (8%)
0/25 (0)
0/17 (0)
DA:
All tested negative
15
 detection with
ement ﬁxation
13
 detection 157 rodents
45 cows
33 buffaloes
46 sheep
48 goats
6/157(3.8%)
0
0
1(2.57%)
1(2.083%)
9
s 40 wild orangutans,
31 semi-captive
orangutans
5/40 (13%) wild, 1/31 (3%)
semi-captive
62
ucleotide
g,
ation detection
NA 25
ation in the
 cell line AP61
eudoscutellaris);
tion of isolates
noﬂuorescence
s-speciﬁc
ascitic ﬂuid and
 by
ent ﬁxation or
tion tests
NA 49
s.
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transmission of the virus.54
However, on Yap Island, in the Federated States of Micronesia,
the most prevalent among the 12 mosquito species belonging to
four genera collected was Aedes henselli, and pooled specimens
tested negative for ZIKV in two studies; consequently, there is
uncertainty about the vector.17,55 The laboratory inoculation of
ZIKV into this mosquito was conducted on Yap Island, with 80%
being colonized (when a high inoculum was provided), among
which 23% developed infection.55 Similarly, in French Polynesia,
where an extended epidemic occurred in October 2013, the
prevalence of A. henselli is higher than any other species,
supposedly rendering it a vector for ZIKV; however, no study
has been conducted to detect the virus in pooled specimens,24 and
at the peak of the epidemic, the entomological study pointed at A.
aegypti and Aedes polynesiensis.19
In Brazil, transmission has been attributed to A. aegypti and A.
albopictus. A. aegypti can be found in rural and urban areas
transmitting chikungunya virus and four dengue serotypes, but A.
albopictus is prevalent in the country.2,31 Human travel among
several commercial urban areas allows for the rapid movement of
vectors (in cars, trucks, planes) along with the infected humans.
A. albopictus has colonized almost every Mediterranean country
and continues to spread through Central and Northern Europe.
Aedes japonicus has spread widely in Central Europe, Aedes
atropalpus in Northern Italy and the Netherlands, Aedes koreicus
on the Swiss–Italian border, Belgium,56 and Germany, and A.
aegypti has established itself on Madeira and around the Black Sea
coast (Russia, Abkhazia, Georgia).29
Similar to all arboviruses, ZIKV vectors are inﬂuenced by animal
population density. Thus, ZIKV could reveal a surprising vector,
reservoir, and amplifying host range should it be introduced into
novel tropical or temperate natural ecosystems, including Eur-
ope.25,57 Additionally, vectors such as A. aegypti and A. dalzieli,
which feed on several animal species and humans, enhance the
transmission rate, as well as concurrent infections and the
recombination and reassortment of the genetic material of ZIKV
strains.24,57
As A. aegypti and A. albopictus thrive in stagnant water
collections like those in peri-domestic water supplies used in
the absence of piped water provision, proliferation may be
encouraged by human population growth or the migratory waves
from areas of civil upheaval and the possible subsequent formation
of uncontrolled slums. Therefore, consistent public awareness
about the signiﬁcance of eliminating any peri-domestic stagnant
water is of critical public health importance.56,58–60
8. Animal hosts
The virus reservoir was not identiﬁed in a 1947 study in Zika
Forest, Uganda, where ZIKV was ﬁrst isolated from rhesus
monkeys.5 The monkeys displayed mild or absent clinical
presentations, while 5 days after experimental infection, they
developed neutralizing antibodies.38 Additionally, anti-ZIKV anti-
bodies were detected in wild mammals in Senegal in 1967–1968.61
In 1969, in Zika Forest, ZIKV was isolated from samples taken from
monkeys.12 In Lombok, Indonesia, in 1978, anti-ZIKV antibodies
were detected in ducks, goats, cows, horses, bats, and carabaos
(water buffalo), but not in chickens, rats, or wild birds, indicating
the widespread circulation of the virus in domestic animals.15 The
question of whether birds transfer the virus over long distances
remains unanswered.15
In 1982 in Gabon, antibodies against the virus were again
detected in monkeys.13 In 1983, antibodies against ZIKV were
detected in Pakistan among rodents, domestic sheep, and goats, as
well as in human sera.9 Samples collected in 1996–1997 from wildand semi-captive orangutans in Borneo, Malaysia, tested positive
for anti-ZIKV antibodies.62 Samples collected from monkeys in
West Africa from 1968 through 2002 were examined and the virus
detected with RT-PCR,25 and samples collected between 1962 and
2008 from monkeys in West Africa tested positive for speciﬁc ZIKV
antigens with serology assays (Table 3).49
The antibody detection assays run the risk of cross-reaction
with other ﬂaviviruses co-circulating with the ZIKV, thus
challenging the safe interpretation of published data. Furthermore,
early laboratory methods for the detection of antibodies were of
uncertain speciﬁcity and sensitivity, and antigen and molecular
assays had not been developed.
9. Conclusions
There are few entomological and vector capacity studies and
limited literature regarding the investigation of the prevalence of
the virus in wild and domestic animals in temperate and tropical
climates. This is probably because the virus has caused mild or no
clinical symptoms in humans and animals until recently.
The dissemination of ZIKV throughout the Paciﬁc and South
America after the French Polynesia outbreak of ZIKV in 2013 is not
in doubt. There is no information about the possibility of trans-
ovarian transmission of the virus in mosquitoes. The virus has been
identiﬁed in the genera Aedes, Anopheles, and Mansonia only in
Africa, and there has been no such pooled specimen examination of
these genera in Asia, the Paciﬁc, or the Americas. In the Paciﬁc and
Southeast Asia, however, experimental inoculation of A. aegypti
and A. henselli was successful.
A. albopictus has expanded worldwide and can adapt to distinct
ecosystems and trigger arboviral outbreaks. A. aegypti, which is
prevalent in densely populated areas of South America, is
recognized as difﬁcult to eradicate and control.31
There are concerns about the vast majority of asymptomatic
while contagious infections, the recent neurological complications
and sequelae in adults and fetuses/newborns,25 and the potential
genetic evolution of this RNA virus, which pose a threat for
subsequent novel neurological and other manifestations. This is a
vector-borne infection that can be transmitted via sexual
intercourse.
In summary, there is insufﬁcient information regarding the
animal reservoirs and ampliﬁcation hosts, including domestic
animals, and the vectors of ZIKV, as well as the vector capacity of
the genus Aedes and genus Anopheles. This represents a public
health emergency, and it is essential that we improve our
understanding of these factors because they will deﬁne the
transmission dynamics and geographic distribution of ZIKV, as
well as indicate the timing and scale of environmental public
health interventions.
Ethical approval: Approval was not required.
Conﬂict of interest: None declared.
References
1. Ventura CV, Maia M, Ventura BV, Linden VV, Araujo EB, Ramos RC, et al.
Ophthalmological ﬁndings in infants with microcephaly and presumable
intra-uterus Zika virus infection. Arq Bras Oftalmol 2016;79:1–3.
2. Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates M, et al.
Unexpected and rapid spread of Zika virus in the Americas—implications for
public health preparedness for mass gatherings at the 2016 Brazil Olympic
Games. Int J Infect Dis 2016;44:11–5.
3. Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, Kolenc M, et al.
Zika virus associated with microcephaly. N Engl J Med 2016;374:951–8.
4. Rubin EJ, Greene MF, Baden LR. Zika virus and microcephaly. N Engl J Med
2016;374:984–5.
5. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological
speciﬁcity. Trans R Soc Trop Med Hyg 1952;46:509–20.
6. Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz DD, Cavalcanti DP, Pessoa
A, et al. Brazilian Medical Genetics Society—Zika Embryopathy Task Force.
R. Vorou / International Journal of Infectious Diseases 48 (2016) 85–9090Possible association between Zika virus infection and microcephaly—Brazil,
2015. MMWR Morb Mortal Wkly Rep 2016;65:59–62.
7. Prata A. Yellow fever. Mem Inst Oswaldo Cruz 2000;95(Suppl 1):183–7.
8. Fagbami AH. Zika virus infections in Nigeria: virological and seroepidemiolo-
gical investigations in Oyo State. J Hyg (Lond) 1979;83:213–9.
9. Darwish MA, Hoogstraal H, Roberts TJ, Ahmed IP, Omar F. A sero-epidemiologi-
cal survey for certain arboviruses (Togaviridae) in Pakistan. Trans R Soc Trop Med
Hyg 1983;77:442–5.
10. Haddow AJ, Williams MC, Woodall JP, Simpson DI, Goma LK. Twelve isolations
of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a
Uganda Forest. Bull World Health Organ 1964;31:57–69.
11. Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti
mosquitoes in Malaysia. Am J Trop Med Hyg 1969;18:411–5.
12. McCrae AW, Kirya BG. Yellow fever and Zika virus epizootics and enzootics in
Uganda. Trans R Soc Trop Med Hyg 1982;76:552–62.
13. Saluzzo JF, Ivanoff B, Languillat G, Georges AJ. [Serological survey for arbovirus
antibodies in the human and simian populations of the South-East of Gabon
(author’s transl)]. Bull Soc Pathol Exot Filiales 1982;75:262–6.
14. Olson JG, Ksiazek TG, Suhandiman, Triwibowo. Zika virus, a cause of fever in
Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981;75:389–93.
15. Olson JG, Ksiazek TG, Gubler DJ, Lubis SI, Simanjuntak G, Lee VH, et al. A survey
for arboviral antibodies in sera of humans and animals in Lombok, Republic of
Indonesia. Ann Trop Med Parasitol 1983;77:131–7.
16. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanﬁeld
SM, Duffy MR. Genetic and serologic properties of Zika virus associated
with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:
1232–9.
17. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika
virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med
2009;360:2536–43.
18. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the
Paciﬁc area. Clin Microbiol Infect 2014;20:O595–6.
19. Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso T, Herida M. Current Zika
virus epidemiology and recent epidemics. Med Mal Infect 2014;44:302–7.
20. Buathong R, Hermann L, Thaisomboonsuk B, Rutvisuttinunt W, Klungthong C,
Chinnawirotpisan P, et al. Detection of Zika virus infection in Thailand, 2012–
2014. Am J Trop Med Hyg 2015;93:380–3.
21. Kwong JC, Druce JD, Leder K. Zika virus infection acquired during brief travel to
Indonesia. Am J Trop Med Hyg 2013;89:516–7.
22. Heang V, Yasuda CY, Sovann L, Haddow AD, Travassos da Rosa AP, Tesh RB,
Kasper MR. Zika virus infection, Cambodia, 2010. Emerg Infect Dis 2012;18:
349–51.
23. Zanluca C, de Melo VC, Mosimann AL, Dos Santos GI, Dos Santos CN, Luz K. First
report of autochthonous transmission of Zika virus in Brazil. Mem Instit Oswaldo
Cruz 2015;110:569–72.
24. Musso D. Zika virus transmission from French Polynesia to Brazil. Emerg Infect
Dis 2015;21:1887.
25. Faye O, Freire CC, Iamarino A, Faye O, de Oliveira JV, Diallo M, et al. Molecular
evolution of Zika virus during its emergence in the 20th century. PLoS Negl Trop
Dis 2014;8:e2636.
26. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus
Flavivirus. J Virol 1998;72:73–83.
27. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet HP, et al. Zika
virus, French Polynesia, South Paciﬁc, 2013. Emerg Infect Dis 2014;20:1085–6.
28. Kuno G, Chang GJ. Full-length sequencing and genomic characterization of
Bagaza, Kedougou, and Zika viruses. Arch Virol 2007;152:687–96.
29. Schaffner F, Medlock JM, Van Bortel W. Public health signiﬁcance of invasive
mosquitoes in Europe. Clin Microbiol Infect 2013;19:685–92.
30. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow
AD, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA.
Emerg Infect Dis 2011;17:880–2.
31. Marcondes CB, Ximenes MF. Zika virus in Brazil and the danger of infestation by
Aedes (Stegomyia) mosquitoes. Rev Soc Bras Med Trop 2015;49(1):4–10. http://
dx.doi.org/10.1590/0037-8682-0220-2015
32. Musso D, Cao-Lormeau VM, Gubler DJ. Zika virus: following the path of dengue
and chikungunya? Lancet 2015;386:243–4.
33. Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of
Zika virus in saliva. J Clin Virol 2015;68:53–5.
34. Petersen EE, Staples JE, Meaney-Delman D, Fischer M, Ellington SR, Callaghan
WM, Jamieson DJ. Interim guidelines for pregnant women during a Zika
virus outbreak—United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:
30–3.
35. Marano G, Pupella S, Vaglio S, Liumbruno GM, Grazzini G. Zika virus and the
never-ending story of emerging pathogens and transfusion medicine. Blood
Transfus 2015;1–6.
36. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, et al. Zika virus
in Gabon (Central Africa)—2007: a new threat from Aedes albopictus? PLoS Negl
Trop Dis 2014;8:e2681.37. Macnamara FN. Zika virus: a report on three cases of human infection during an
epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954;48:139–45.
38. Dick GW. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop
Med Hyg 1952;46:521–34.
39. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, et al. Zika virus
infection complicated by Guillain–Barre´ syndrome—case report, French Poly-
nesia, December 2013. Euro Surveill 2014;19(9). pii: 20720. PMID: 24626205.
40. Roze B, Najioullah F, Ferge JL, Apetse K, Brouste Y, Cesaire R, et al., GBS Zika
Working Group. Zika virus detection in urine from patients with Guillain–Barre´
syndrome on Martinique, January 2016. Euro Surveill 2016;21(9). http://
dx.doi.org/10.2807/1560-7917.ES.2016.21.9.30154. PMID: 26967758.
41. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al.
Guillain–Barre´ syndrome outbreak associated with Zika virus infection in
French Polynesia: a case–control study. Lancet 2016 Feb 29. doi: 101016/
S0140-6736(16)00562-6 [Epub ahead of print].
42. Roth A, Mercier A, Lepers C, Hoy D, Duituturaga S, Benyon E, et al. Concurrent
outbreaks of dengue, chikungunya and Zika virus infections—an unprecedented
epidemic wave of mosquito-borne viruses in the Paciﬁc 2012–2014. Euro
Surveill 2014;19(41). pii: 20929. PMID: 25345518.
43. Vorou R. Letter to the editor: diagnostic challenges to be considered regarding
Zika virus in the context of the presence of the vector Aedes albopictus in Europe.
Euro Surveill 2016;21(10). http://dx.doi.org/10.2807/1560-7917.ES.2016.21.
10.30161. PMID: 26988027.
44. Centers for Disease Control and Prevention. Revised diagnostic testing for Zika,
chikungunya, and dengue viruses in US public health laboratories. Atlanta:
CDC; 2016. Available at: http://wwwcdcgov/zika/pdfs/denvchikvzikv-testing-
algorithmpdf.(accessed February 26, 2016).
45. Zammarchi L, Tappe D, Fortuna C, Remoli ME, Gunther S, Venturi G, et al. Zika
virus infection in a traveller returning to Europe from Brazil, March 2015. Euro
Surveill 2015;20(23). pii: 21153. PMID: 26084316.
46. Faye O, Faye O, Diallo D, Diallo M, Weidmann M, Sall AA. Quantitative real-time
PCR detection of Zika virus and evaluation with ﬁeld-caught mosquitoes. Virol J
2013;10:311.
47. Weinbren MP, Williams MC. Zika virus: further isolations in the Zika area, and
some studies on the strains isolated. Trans R Soc Trop Med Hyg 1958;52:263–8.
48. Berthet N, Nakoune E, Kamgang B, Selekon B, Descorps-Declere S, Gessain A,
Manuguerra JC, Kazanji M. Molecular characterization of three Zika ﬂaviviruses
obtained from sylvatic mosquitoes in the Central African Republic. Vector Borne
Zoonotic Dis 2014;14:862–5.
49. Althouse BM, Hanley KA, Diallo M, Sall AA, Ba Y, Faye O, et al. Impact of climate
and mosquito vector abundance on sylvatic arbovirus circulation dynamics in
Senegal. Am J Trop Med Hyg 2015;92:88–97.
50. Diallo D, Sall AA, Diagne CT, Faye O, Faye O, Ba Y, et al. Zika virus emergence in
mosquitoes in southeastern Senegal, 2011. PLoS One 2014;9:e109442.
51. Ngoagouni C, Kamgang B, Nakoune´ E, Paupy C, Kazanji M. Invasion of Aedes
albopictus (Diptera: Culicidae) into Central Africa: what consequences for
emerging diseases? Parasit Vectors 2015; 8:191.
52. Kampango A, Abilio AP. The Asian tiger hunts in Maputo city—the ﬁrst con-
ﬁrmed report of Aedes (Stegomyia) albopictus (Skuse, 1895) in Mozambique.
Parasit Vectors 2016;9:76.
53. Calvez E, Guillaumot L, Millet L, Marie J, Bossin H, Rama V, et al. Genetic
diversity and phylogeny of Aedes aegypti, the main arbovirus vector in the
Paciﬁc. PLoS Negl Trop Dis 2016;10:e0004374.
54. Wong PS, Li MZ, Chong CS, Ng LC, Tan CH. Aedes (Stegomyia) albopictus (Skuse): a
potential vector of Zika virus in Singapore. PLoS Negl Trop Dis 2013;7:e2348.
55. Ledermann JP, Guillaumot L, Yug L, Saweyog SC, Tided M, Machieng P, et al.
Aedes henselli as a potential vector of chikungunya and Zika viruses. PLoS Negl
Trop Dis 2014;8:e3188.
56. Boukraa S, Dekoninck W, Versteirt V, Schaffner F, Coosemans M, Haubruge E,
Francis F. Updated checklist of the mosquitoes (Diptera: Culicidae) of Belgium. J
Vector Ecol 2015;40:398–407.
57. Kuno G, Chang GJ. Biological transmission of arboviruses: reexamination of and
new insights into components, mechanisms, and unique traits as well as their
evolutionary trends. Clin Microbiol Rev 2005;18:608–37.
58. Erguler K, Smith-Unna SE, Waldock J, Proestos Y, Christophides GK, Lelieveld J,
Parham PE. Large-scale modelling of the environmentally-driven population
dynamics of temperate Aedes albopictus (Skuse). PLoS One 2016;11:e0149282.
59. Valerio L, Roure S, Fernandez-Rivas G, Ballesteros AL, Ruiz J, Moreno N, et al.
Arboviral infections diagnosed in a European area colonized by Aedes albo-
pictus (2009-2013, Catalonia, Spain). Travel Med Infect Dis 2015;13:415–21.
60. Werner D, Zielke DE, Kampen H. First record of Aedes koreicus (Diptera:
Culicidae) in Germany. Parasitol Res 2015;115:1331–4.
61. Bres P. [Recent data from serological surveys on the prevalence of arbovirus
infections in Africa, with special reference to yellow fever]. Bull World Health
Organ 1970;43:223–67.
62. Wolfe ND, Kilbourn AM, Karesh WB, Rahman HA, Bosi EJ, Cropp BC, et al.
Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med
Hyg 2001;64:310–6.
